ICO — Iconovo AB Share News
0.000.00%
Last trade - 00:00- SEK93.86m
- SEK67.28m
- SEK1.10m
Brief: EPO To Approve Iconovo's Patent Application For Icores Inhaler Platform
Brief: Iconovo Receives SEK 670,000 Grant From Innowwide
Brief: Iconovo Q4 Operating Loss SEK 10.8 Mln
Brief: Iconovo And Lonza Partner On Formulation Development Of Intranasal Biologic
Brief: Iconovo To Get About SEK 28.7 Mln From Rights Issue
Brief: Iconovo To Raise SEK 28.7 Mln Through Rights Issue
Brief: Iconovo Q3 Operating Loss SEK 11.1 Million
Brief: Iconovo Decides On Rights Issue Of Units Of SEK 28.7 Mln
Brief: Iconovo Gets Positive FDA Guidance on Icopre Substitutability
Brief: Iconovo Terminates All Agreements With ISR Immune System Regulation
Brief: Iconovo Develops Intranasal Semaglutide For Obesity Treatment
Brief: Iconovo Files Patent Application For Inhaled GLP-1 Products
Brief: Iconovo Gets Patent Protection For Icores In China
Brief: Iconovo Q1 Oper Loss Narrows To SEK 9.6 Mln
Brief: Iconovo Gets Grant Of SEK 680,000 From Innowwide For Market Efforts In South Korea
Brief: Iconovo Q4 Oper Loss Narrows To SEK 10 Mln
Brief: Iconovo Carries Out Directed Share Issue
Founder Mats Johansson Acquires Shares
Brief: Iconovo Q3 Operating Loss SEK 10 Million